Prioritize skills above infrastructure in UK meds manufacturing, expert says

Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities.

But — with this money allocated to the physical infrastructure of advanced medicines manufacturing — they have also stressed that creating a trained workforce must be a priority. 

Ivan Wall, co-director of Resilience, the UK’s first medicines manufacturing skills center of excellence, said: “This announcement in the budget to support life sciences is a welcome step for the UK medicines manufacturing sector.